Rhituparna Nandi

2018- IISER Bhopal 
"Rhituparna Nandi"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bhowmik D, Nandi R, Prakash A, et al. (2021) Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. Heliyon. 7: e06515
Saha S, Nandi R, Vishwakarma P, et al. (2021) Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach. Frontiers in Pharmacology. 12: 634047
Bhowmik D, Nandi R, Jagadeesan R, et al. (2020) Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 104451
Bhowmik D, Jagadeesan R, Rai P, et al. (2020) Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approaches. Journal of Biomolecular Structure & Dynamics. 1-24
See more...